{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-28T12:29:46.554029+00:00",
  "news": [
    {
      "title": "Amgen Inc. $AMGN is Federated Hermes Inc.'s 10th Largest Position - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNUDc1QzhUcy1Wa2dHRGg1WG5mdXdWQ3J3UmFvamhybWdCUDl0SFpER3BkaGE0eUtIUld5Qy1qVDdJUjd3bDQ3RGVQam9WbkFqWVdJSkJPTHBjQWJqRU9wZjBfZnZzV2pyZjdTakZQVGFZbzhJR0FVOHBGcDlycktMcW8tQ2g1Vm41Y3ZlOVdXYWZDWWhXdDN3Zm83TXk1TEdESFFaSVdQZkI2RUU2ajhlVy13VlpKUWhSeG1iLWZmVQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNUDc1QzhUcy1Wa2dHRGg1WG5mdXdWQ3J3UmFvamhybWdCUDl0SFpER3BkaGE0eUtIUld5Qy1qVDdJUjd3bDQ3RGVQam9WbkFqWVdJSkJPTHBjQWJqRU9wZjBfZnZzV2pyZjdTakZQVGFZbzhJR0FVOHBGcDlycktMcW8tQ2g1Vm41Y3ZlOVdXYWZDWWhXdDN3Zm83TXk1TEdESFFaSVdQZkI2RUU2ajhlVy13VlpKUWhSeG1iLWZmVQ?oc=5\" target=\"_blank\">Amgen Inc. $AMGN is Federated Hermes Inc.'s 10th Largest Position</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-01-28T11:24:36+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Litigation over State Attempts to Lower Drug Costs: Prescription Drug Affordability Boards (PDABs) - EveryCRSReport.com",
      "link": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE9oX09uaFpaRFhhVE1yY1ZzS0JjbWhSR0wtV3lrWDV5NVd2UEhGV0plZVYxd1c0SURUcTd6MFNNS2UyTjdQQWlFU2x6dG84dmhXZ0pUd2hZUUdQaVp1dUN3YWFn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9oX09uaFpaRFhhVE1yY1ZzS0JjbWhSR0wtV3lrWDV5NVd2UEhGV0plZVYxd1c0SURUcTd6MFNNS2UyTjdQQWlFU2x6dG84dmhXZ0pUd2hZUUdQaVp1dUN3YWFn?oc=5\" target=\"_blank\">Litigation over State Attempts to Lower Drug Costs: Prescription Drug Affordability Boards (PDABs)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">EveryCRSReport.com</font>",
      "published": "2026-01-28T07:31:29+00:00",
      "source": "EveryCRSReport.com"
    },
    {
      "title": "Amgen R&D EVP James Bradner On Upcoming Readouts And Doing Deals Around New Capabilities - Citeline News & Insights",
      "link": "https://news.google.com/rss/articles/CBMigwJBVV95cUxNWURzdlRxdXRsZDRXdS1xeUZuTXNwdThIdXVGM2RZcnlORFJoSnBCWG5zdmR2M2dUbm41d1VUdFREbDl6WndWM0xtQWFfZjVHcXlUUlVJMzI2SUU1aGI1STlzNUEtZnJZUkJzZG04WjQ2Z3JPN0plUnM2a1BJelhZREViWl92andPdGhoOWpGMWxsTGZ5Z0txVG1EU3lXUEdCZTBibWRWcUROZTBqVDJlOXc4Z1BTaU96MnZrdXRKanZVRnZQR3lBd3I3SS1ucTNIM1BPOUt2RTFEY05Ia3VrU0JlQmVlZktlTGk1MHlaZGpRbURWRGZQdkcwQXFIeVdIZktZ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwJBVV95cUxNWURzdlRxdXRsZDRXdS1xeUZuTXNwdThIdXVGM2RZcnlORFJoSnBCWG5zdmR2M2dUbm41d1VUdFREbDl6WndWM0xtQWFfZjVHcXlUUlVJMzI2SUU1aGI1STlzNUEtZnJZUkJzZG04WjQ2Z3JPN0plUnM2a1BJelhZREViWl92andPdGhoOWpGMWxsTGZ5Z0txVG1EU3lXUEdCZTBibWRWcUROZTBqVDJlOXc4Z1BTaU96MnZrdXRKanZVRnZQR3lBd3I3SS1ucTNIM1BPOUt2RTFEY05Ia3VrU0JlQmVlZktlTGk1MHlaZGpRbURWRGZQdkcwQXFIeVdIZktZ?oc=5\" target=\"_blank\">Amgen R&amp;D EVP James Bradner On Upcoming Readouts And Doing Deals Around New Capabilities</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Citeline News & Insights</font>",
      "published": "2026-01-27T18:58:37+00:00",
      "source": "Citeline News & Insights"
    },
    {
      "title": "Is It Time To Reassess Amgen (AMGN) After Strong Multi Year Share Price Gains - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Is It Time To Reassess Amgen (AMGN) After Strong Multi Year Share Price Gains</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-27T20:32:31+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for - Finviz",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxONklDNW84OWptX2JPSGlRNUh2ajFTU1R1NmxTdk54WURxWGJQdGN0UGhqNk0tMDc2YWdscGp1R3lRblNqUGIxVkxCcy1sX19xdmMzdkpmdGFBZGF1N1ZKeFNhQmEzdTBONnp1cEptMVoxeVNMZUN6dEhUSHFOa0huREYwYWNoT3F3R3Z5VkpPYm0ycllGaEo2bFp0QU12SllVNmJsZG5WNU02dGFueE5CTnlB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxONklDNW84OWptX2JPSGlRNUh2ajFTU1R1NmxTdk54WURxWGJQdGN0UGhqNk0tMDc2YWdscGp1R3lRblNqUGIxVkxCcy1sX19xdmMzdkpmdGFBZGF1N1ZKeFNhQmEzdTBONnp1cEptMVoxeVNMZUN6dEhUSHFOa0huREYwYWNoT3F3R3Z5VkpPYm0ycllGaEo2bFp0QU12SllVNmJsZG5WNU02dGFueE5CTnlB?oc=5\" target=\"_blank\">Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Finviz</font>",
      "published": "2026-01-27T16:17:11+00:00",
      "source": "Finviz"
    },
    {
      "title": "Amgen CEO says weight loss drug can address 'patient persistence issue' - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5\" target=\"_blank\">Amgen CEO says weight loss drug can address 'patient persistence issue'</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2026-01-13T08:00:00+00:00",
      "source": "CNBC"
    },
    {
      "title": "Ro partners with Amgen to study barriers to obesity care, GLP-1 access - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5\" target=\"_blank\">Ro partners with Amgen to study barriers to obesity care, GLP-1 access</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2026-01-13T08:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5\" target=\"_blank\">AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2026-01-06T08:00:00+00:00",
      "source": "PR Newswire"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    },
    {
      "title": "Amgen History - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE53MklERTNSbkNVaXhYQ3dPcEtDRU1uTW5mLUdxSGFtZ0wxMmFZSlQ1SnZkY1hZOFZ1RmRsZjNXMGYtM1hQXzl0R0NJSmtQLVJnYzlN?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE53MklERTNSbkNVaXhYQ3dPcEtDRU1uTW5mLUdxSGFtZ0wxMmFZSlQ1SnZkY1hZOFZ1RmRsZjNXMGYtM1hQXzl0R0NJSmtQLVJnYzlN?oc=5\" target=\"_blank\">Amgen History</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2020-12-12T03:24:17+00:00",
      "source": "Amgen"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-27",
      "close": 351.32000732421875
    },
    "history": [
      {
        "date": "2026-01-16",
        "close": 330.4100036621094
      },
      {
        "date": "2026-01-20",
        "close": 331.0
      },
      {
        "date": "2026-01-21",
        "close": 343.6000061035156
      },
      {
        "date": "2026-01-22",
        "close": 347.07000732421875
      },
      {
        "date": "2026-01-23",
        "close": 344.75
      },
      {
        "date": "2026-01-26",
        "close": 349.69000244140625
      },
      {
        "date": "2026-01-27",
        "close": 351.32000732421875
      }
    ],
    "name": "Amgen Inc."
  }
}